The stock market heads into an interesting round of earnings, led by Walmart, RIvian, and a key Warren Buffett stock.

As the incidence of genetic disorders increases, there is a corresponding rise in the demand for molecular biology enzymes, kits, and reagents essential for conducting tests. These tools are vital for ...

Pearl, the global leader in dental AI solutions, today announced a partnership with Open Dental Software to integrate its ...

Glomus tumours are uncommon, benign neoplasms originating from the glomus body, predominantly affecting adults between 20–40 years of ...

Tracey Technologies’ iTrace uses ray tracing technology to obtain precise measurements of the eye’s internal and external ...